aluates Reports

$ 0.0

Automative

Global Tocilizumab Biosimilars Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-20H18260

BUY CHAPTERS

Global Tocilizumab Biosimilars Market Research Report 2024

Code: QYRE-Auto-20H18260

Report

August 2024

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Biogen

Biogen Inc

Fresenius Kabi

Hetero

Bio-Thera Solutions

Zhuhai Livzon Biotechnology

Hangzhou Bozhirui Biopharmaceutical

Tocilizumab Biosimilars Market

Tocilizumab biosimilars are biopharmaceutical products developed to be highly similar to the originator biologic drug tocilizumab.Tocilizumab is a monoclonal antibody that targets the interleukin-6 receptor (IL-6R),blocking IL-6 signaling and thereby modulating the inflammatory response.

The global Tocilizumab Biosimilars market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Tocilizumab Biosimilars is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tocilizumab Biosimilars is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Tocilizumab Biosimilars include Biogen, Fresenius Kabi, Hetero, Bio-Thera Solutions, Zhuhai Livzon Biotechnology, Hangzhou Bozhirui Biopharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tocilizumab Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tocilizumab Biosimilars.

The Tocilizumab Biosimilars market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tocilizumab Biosimilars market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tocilizumab Biosimilars manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tocilizumab Biosimilars Market Report

Report Metric	Details
Report Name	Tocilizumab Biosimilars Market
Segment by Type	Intravenous Infusion Subcutaneous Injection
Segment by Application	Rheumatoid Arthritis Juvenile Idiopathic Arthritis Giant Cell Arteritis Cytokine Release Syndrome Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Biogen, Fresenius Kabi, Hetero, Bio-Thera Solutions, Zhuhai Livzon Biotechnology, Hangzhou Bozhirui Biopharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tocilizumab Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tocilizumab Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tocilizumab Biosimilars Market report?

Ans: The main players in the Tocilizumab Biosimilars Market are Biogen, Fresenius Kabi, Hetero, Bio-Thera Solutions, Zhuhai Livzon Biotechnology, Hangzhou Bozhirui Biopharmaceutical

What are the Application segmentation covered in the Tocilizumab Biosimilars Market report?

Ans: The Applications covered in the Tocilizumab Biosimilars Market report are Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Giant Cell Arteritis, Cytokine Release Syndrome, Other

What are the Type segmentation covered in the Tocilizumab Biosimilars Market report?

Ans: The Types covered in the Tocilizumab Biosimilars Market report are Intravenous Infusion, Subcutaneous Injection

Recommended Reports

Biosimilars Market

Antibody Drugs

Biologics & Excipients

1 Tocilizumab Biosimilars Market Overview

1.1 Product Definition

1.2 Tocilizumab Biosimilars by Type

1.2.1 Global Tocilizumab Biosimilars Market Value Comparison by Type (2024-2030)

1.2.2 Intravenous Infusion

1.2.3 Subcutaneous Injection

1.3 Tocilizumab Biosimilars by Application

1.3.1 Global Tocilizumab Biosimilars Market Value by Application (2024-2030)

1.3.2 Rheumatoid Arthritis

1.3.3 Juvenile Idiopathic Arthritis

1.3.4 Giant Cell Arteritis

1.3.5 Cytokine Release Syndrome

1.3.6 Other

1.4 Global Tocilizumab Biosimilars Market Size Estimates and Forecasts

1.4.1 Global Tocilizumab Biosimilars Revenue 2019-2030

1.4.2 Global Tocilizumab Biosimilars Sales 2019-2030

1.4.3 Global Tocilizumab Biosimilars Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Tocilizumab Biosimilars Market Competition by Manufacturers

2.1 Global Tocilizumab Biosimilars Sales Market Share by Manufacturers (2019-2024)

2.2 Global Tocilizumab Biosimilars Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Tocilizumab Biosimilars Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Tocilizumab Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Tocilizumab Biosimilars, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Tocilizumab Biosimilars, Product Type & Application

2.7 Global Key Manufacturers of Tocilizumab Biosimilars, Date of Enter into This Industry

2.8 Global Tocilizumab Biosimilars Market Competitive Situation and Trends

2.8.1 Global Tocilizumab Biosimilars Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Tocilizumab Biosimilars Players Market Share by Revenue

2.8.3 Global Tocilizumab Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Tocilizumab Biosimilars Market Scenario by Region

3.1 Global Tocilizumab Biosimilars Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Tocilizumab Biosimilars Sales by Region: 2019-2030

3.2.1 Global Tocilizumab Biosimilars Sales by Region: 2019-2024

3.2.2 Global Tocilizumab Biosimilars Sales by Region: 2025-2030

3.3 Global Tocilizumab Biosimilars Revenue by Region: 2019-2030

3.3.1 Global Tocilizumab Biosimilars Revenue by Region: 2019-2024

3.3.2 Global Tocilizumab Biosimilars Revenue by Region: 2025-2030

3.4 North America Tocilizumab Biosimilars Market Facts & Figures by Country

3.4.1 North America Tocilizumab Biosimilars Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Tocilizumab Biosimilars Sales by Country (2019-2030)

3.4.3 North America Tocilizumab Biosimilars Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Tocilizumab Biosimilars Market Facts & Figures by Country

3.5.1 Europe Tocilizumab Biosimilars Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Tocilizumab Biosimilars Sales by Country (2019-2030)

3.5.3 Europe Tocilizumab Biosimilars Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Tocilizumab Biosimilars Market Facts & Figures by Region

3.6.1 Asia Pacific Tocilizumab Biosimilars Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Tocilizumab Biosimilars Sales by Region (2019-2030)

3.6.3 Asia Pacific Tocilizumab Biosimilars Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Tocilizumab Biosimilars Market Facts & Figures by Country

3.7.1 Latin America Tocilizumab Biosimilars Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Tocilizumab Biosimilars Sales by Country (2019-2030)

3.7.3 Latin America Tocilizumab Biosimilars Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Tocilizumab Biosimilars Market Facts & Figures by Country

3.8.1 Middle East and Africa Tocilizumab Biosimilars Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Tocilizumab Biosimilars Sales by Country (2019-2030)

3.8.3 Middle East and Africa Tocilizumab Biosimilars Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Tocilizumab Biosimilars Sales by Type (2019-2030)

4.1.1 Global Tocilizumab Biosimilars Sales by Type (2019-2024)

4.1.2 Global Tocilizumab Biosimilars Sales by Type (2025-2030)

4.1.3 Global Tocilizumab Biosimilars Sales Market Share by Type (2019-2030)

4.2 Global Tocilizumab Biosimilars Revenue by Type (2019-2030)

4.2.1 Global Tocilizumab Biosimilars Revenue by Type (2019-2024)

4.2.2 Global Tocilizumab Biosimilars Revenue by Type (2025-2030)

4.2.3 Global Tocilizumab Biosimilars Revenue Market Share by Type (2019-2030)

4.3 Global Tocilizumab Biosimilars Price by Type (2019-2030)

5 Segment by Application

5.1 Global Tocilizumab Biosimilars Sales by Application (2019-2030)

5.1.1 Global Tocilizumab Biosimilars Sales by Application (2019-2024)

5.1.2 Global Tocilizumab Biosimilars Sales by Application (2025-2030)

5.1.3 Global Tocilizumab Biosimilars Sales Market Share by Application (2019-2030)

5.2 Global Tocilizumab Biosimilars Revenue by Application (2019-2030)

5.2.1 Global Tocilizumab Biosimilars Revenue by Application (2019-2024)

5.2.2 Global Tocilizumab Biosimilars Revenue by Application (2025-2030)

5.2.3 Global Tocilizumab Biosimilars Revenue Market Share by Application (2019-2030)

5.3 Global Tocilizumab Biosimilars Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Biogen

6.1.1 Biogen Company Information

6.1.2 Biogen Description and Business Overview

6.1.3 Biogen Tocilizumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Biogen Tocilizumab Biosimilars Product Portfolio

6.1.5 Biogen Recent Developments/Updates

6.2 Fresenius Kabi

6.2.1 Fresenius Kabi Company Information

6.2.2 Fresenius Kabi Description and Business Overview

6.2.3 Fresenius Kabi Tocilizumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Fresenius Kabi Tocilizumab Biosimilars Product Portfolio

6.2.5 Fresenius Kabi Recent Developments/Updates

6.3 Hetero

6.3.1 Hetero Company Information

6.3.2 Hetero Description and Business Overview

6.3.3 Hetero Tocilizumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Hetero Tocilizumab Biosimilars Product Portfolio

6.3.5 Hetero Recent Developments/Updates

6.4 Bio-Thera Solutions

6.4.1 Bio-Thera Solutions Company Information

6.4.2 Bio-Thera Solutions Description and Business Overview

6.4.3 Bio-Thera Solutions Tocilizumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bio-Thera Solutions Tocilizumab Biosimilars Product Portfolio

6.4.5 Bio-Thera Solutions Recent Developments/Updates

6.5 Zhuhai Livzon Biotechnology

6.5.1 Zhuhai Livzon Biotechnology Company Information

6.5.2 Zhuhai Livzon Biotechnology Description and Business Overview

6.5.3 Zhuhai Livzon Biotechnology Tocilizumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Zhuhai Livzon Biotechnology Tocilizumab Biosimilars Product Portfolio

6.5.5 Zhuhai Livzon Biotechnology Recent Developments/Updates

6.6 Hangzhou Bozhirui Biopharmaceutical

6.6.1 Hangzhou Bozhirui Biopharmaceutical Company Information

6.6.2 Hangzhou Bozhirui Biopharmaceutical Description and Business Overview

6.6.3 Hangzhou Bozhirui Biopharmaceutical Tocilizumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Hangzhou Bozhirui Biopharmaceutical Tocilizumab Biosimilars Product Portfolio

6.6.5 Hangzhou Bozhirui Biopharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Tocilizumab Biosimilars Industry Chain Analysis

7.2 Tocilizumab Biosimilars Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Tocilizumab Biosimilars Production Mode & Process

7.4 Tocilizumab Biosimilars Sales and Marketing

7.4.1 Tocilizumab Biosimilars Sales Channels

7.4.2 Tocilizumab Biosimilars Distributors

7.5 Tocilizumab Biosimilars Customers

8 Tocilizumab Biosimilars Market Dynamics

8.1 Tocilizumab Biosimilars Industry Trends

8.2 Tocilizumab Biosimilars Market Drivers

8.3 Tocilizumab Biosimilars Market Challenges

8.4 Tocilizumab Biosimilars Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Biogen

Biogen Inc

Fresenius Kabi

Hetero

Bio-Thera Solutions

Zhuhai Livzon Biotechnology

Hangzhou Bozhirui Biopharmaceutical

List of Tables

Table 1. Global Tocilizumab Biosimilars Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Tocilizumab Biosimilars Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Tocilizumab Biosimilars Market Competitive Situation by Manufacturers in 2023

Table 4. Global Tocilizumab Biosimilars Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Tocilizumab Biosimilars Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Tocilizumab Biosimilars Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Tocilizumab Biosimilars Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Tocilizumab Biosimilars Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Tocilizumab Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Tocilizumab Biosimilars, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Tocilizumab Biosimilars, Product Type & Application

Table 12. Global Key Manufacturers of Tocilizumab Biosimilars, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Tocilizumab Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tocilizumab Biosimilars as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Tocilizumab Biosimilars Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Tocilizumab Biosimilars Sales by Region (2019-2024) & (K Units)

Table 18. Global Tocilizumab Biosimilars Sales Market Share by Region (2019-2024)

Table 19. Global Tocilizumab Biosimilars Sales by Region (2025-2030) & (K Units)

Table 20. Global Tocilizumab Biosimilars Sales Market Share by Region (2025-2030)

Table 21. Global Tocilizumab Biosimilars Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Tocilizumab Biosimilars Revenue Market Share by Region (2019-2024)

Table 23. Global Tocilizumab Biosimilars Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Tocilizumab Biosimilars Revenue Market Share by Region (2025-2030)

Table 25. North America Tocilizumab Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Tocilizumab Biosimilars Sales by Country (2019-2024) & (K Units)

Table 27. North America Tocilizumab Biosimilars Sales by Country (2025-2030) & (K Units)

Table 28. North America Tocilizumab Biosimilars Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Tocilizumab Biosimilars Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Tocilizumab Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Tocilizumab Biosimilars Sales by Country (2019-2024) & (K Units)

Table 32. Europe Tocilizumab Biosimilars Sales by Country (2025-2030) & (K Units)

Table 33. Europe Tocilizumab Biosimilars Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Tocilizumab Biosimilars Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Tocilizumab Biosimilars Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Tocilizumab Biosimilars Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Tocilizumab Biosimilars Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Tocilizumab Biosimilars Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Tocilizumab Biosimilars Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Tocilizumab Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Tocilizumab Biosimilars Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Tocilizumab Biosimilars Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Tocilizumab Biosimilars Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Tocilizumab Biosimilars Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Tocilizumab Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Tocilizumab Biosimilars Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Tocilizumab Biosimilars Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Tocilizumab Biosimilars Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Tocilizumab Biosimilars Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Tocilizumab Biosimilars Sales (K Units) by Type (2019-2024)

Table 51. Global Tocilizumab Biosimilars Sales (K Units) by Type (2025-2030)

Table 52. Global Tocilizumab Biosimilars Sales Market Share by Type (2019-2024)

Table 53. Global Tocilizumab Biosimilars Sales Market Share by Type (2025-2030)

Table 54. Global Tocilizumab Biosimilars Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Tocilizumab Biosimilars Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Tocilizumab Biosimilars Revenue Market Share by Type (2019-2024)

Table 57. Global Tocilizumab Biosimilars Revenue Market Share by Type (2025-2030)

Table 58. Global Tocilizumab Biosimilars Price (US$/Unit) by Type (2019-2024)

Table 59. Global Tocilizumab Biosimilars Price (US$/Unit) by Type (2025-2030)

Table 60. Global Tocilizumab Biosimilars Sales (K Units) by Application (2019-2024)

Table 61. Global Tocilizumab Biosimilars Sales (K Units) by Application (2025-2030)

Table 62. Global Tocilizumab Biosimilars Sales Market Share by Application (2019-2024)

Table 63. Global Tocilizumab Biosimilars Sales Market Share by Application (2025-2030)

Table 64. Global Tocilizumab Biosimilars Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Tocilizumab Biosimilars Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Tocilizumab Biosimilars Revenue Market Share by Application (2019-2024)

Table 67. Global Tocilizumab Biosimilars Revenue Market Share by Application (2025-2030)

Table 68. Global Tocilizumab Biosimilars Price (US$/Unit) by Application (2019-2024)

Table 69. Global Tocilizumab Biosimilars Price (US$/Unit) by Application (2025-2030)

Table 70. Biogen Company Information

Table 71. Biogen Description and Business Overview

Table 72. Biogen Tocilizumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Biogen Tocilizumab Biosimilars Product

Table 74. Biogen Recent Developments/Updates

Table 75. Fresenius Kabi Company Information

Table 76. Fresenius Kabi Description and Business Overview

Table 77. Fresenius Kabi Tocilizumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Fresenius Kabi Tocilizumab Biosimilars Product

Table 79. Fresenius Kabi Recent Developments/Updates

Table 80. Hetero Company Information

Table 81. Hetero Description and Business Overview

Table 82. Hetero Tocilizumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Hetero Tocilizumab Biosimilars Product

Table 84. Hetero Recent Developments/Updates

Table 85. Bio-Thera Solutions Company Information

Table 86. Bio-Thera Solutions Description and Business Overview

Table 87. Bio-Thera Solutions Tocilizumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Bio-Thera Solutions Tocilizumab Biosimilars Product

Table 89. Bio-Thera Solutions Recent Developments/Updates

Table 90. Zhuhai Livzon Biotechnology Company Information

Table 91. Zhuhai Livzon Biotechnology Description and Business Overview

Table 92. Zhuhai Livzon Biotechnology Tocilizumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Zhuhai Livzon Biotechnology Tocilizumab Biosimilars Product

Table 94. Zhuhai Livzon Biotechnology Recent Developments/Updates

Table 95. Hangzhou Bozhirui Biopharmaceutical Company Information

Table 96. Hangzhou Bozhirui Biopharmaceutical Description and Business Overview

Table 97. Hangzhou Bozhirui Biopharmaceutical Tocilizumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Hangzhou Bozhirui Biopharmaceutical Tocilizumab Biosimilars Product

Table 99. Hangzhou Bozhirui Biopharmaceutical Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Tocilizumab Biosimilars Distributors List

Table 103. Tocilizumab Biosimilars Customers List

Table 104. Tocilizumab Biosimilars Market Trends

Table 105. Tocilizumab Biosimilars Market Drivers

Table 106. Tocilizumab Biosimilars Market Challenges

Table 107. Tocilizumab Biosimilars Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Tocilizumab Biosimilars

Figure 2. Global Tocilizumab Biosimilars Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Tocilizumab Biosimilars Market Share by Type: 2023 & 2030

Figure 4. Intravenous Infusion Product Picture

Figure 5. Subcutaneous Injection Product Picture

Figure 6. Global Tocilizumab Biosimilars Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Tocilizumab Biosimilars Market Share by Application: 2023 & 2030

Figure 8. Rheumatoid Arthritis

Figure 9. Juvenile Idiopathic Arthritis

Figure 10. Giant Cell Arteritis

Figure 11. Cytokine Release Syndrome

Figure 12. Other

Figure 13. Global Tocilizumab Biosimilars Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Tocilizumab Biosimilars Market Size (2019-2030) & (US$ Million)

Figure 15. Global Tocilizumab Biosimilars Sales (2019-2030) & (K Units)

Figure 16. Global Tocilizumab Biosimilars Average Price (US$/Unit) & (2019-2030)

Figure 17. Tocilizumab Biosimilars Report Years Considered

Figure 18. Tocilizumab Biosimilars Sales Share by Manufacturers in 2023

Figure 19. Global Tocilizumab Biosimilars Revenue Share by Manufacturers in 2023

Figure 20. Global 5 and 10 Largest Tocilizumab Biosimilars Players: Market Share by Revenue in Tocilizumab Biosimilars in 2023

Figure 21. Tocilizumab Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 22. Global Tocilizumab Biosimilars Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Tocilizumab Biosimilars Sales Market Share by Country (2019-2030)

Figure 24. North America Tocilizumab Biosimilars Revenue Market Share by Country (2019-2030)

Figure 25. United States Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Tocilizumab Biosimilars Sales Market Share by Country (2019-2030)

Figure 28. Europe Tocilizumab Biosimilars Revenue Market Share by Country (2019-2030)

Figure 29. Germany Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Tocilizumab Biosimilars Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Tocilizumab Biosimilars Revenue Market Share by Region (2019-2030)

Figure 36. China Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Tocilizumab Biosimilars Sales Market Share by Country (2019-2030)

Figure 44. Mexico Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Colombia Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East and Africa Tocilizumab Biosimilars Sales Market Share by Country (2019-2030)

Figure 49. Middle East and Africa Tocilizumab Biosimilars Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Tocilizumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Tocilizumab Biosimilars by Type (2019-2030)

Figure 54. Global Revenue Market Share of Tocilizumab Biosimilars by Type (2019-2030)

Figure 55. Global Tocilizumab Biosimilars Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of Tocilizumab Biosimilars by Application (2019-2030)

Figure 57. Global Revenue Market Share of Tocilizumab Biosimilars by Application (2019-2030)

Figure 58. Global Tocilizumab Biosimilars Price (US$/Unit) by Application (2019-2030)

Figure 59. Tocilizumab Biosimilars Value Chain

Figure 60. Tocilizumab Biosimilars Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Tocilizumab Market Research Report 2024

Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024

Global Rituximab Biosimilars Market Research Report 2025

Adalimumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biosimilar of Remicade Market

Trastuzumab Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ranibizumab Drugs and Biosimilars Market Research Report 2024

Global Ustekinumab Biosimilars Market Research Report 2024

Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biologics and Biosimilars Market Research Report 2025

Global Omalizumab Biosimilars Market Research Report 2025

Global Psoriasis Biosimilar Market Research Report 2024

Adalimumab Humira and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Omalizumab Monoclonal Antibody Biosimilars Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions